WebMD Medical News
Laura J. Martin, MD
Sept. 6, 2011 -- Once again, researchers are questioning the wisdom of guidelines that do not recommend annual mammograms for women aged 40-49 who are at average risk of breast cancer.
In November 2009, the U.S. Preventive Services Task Force (USPSTF) issued revised guidelines suggesting women 40-49 discuss the risks and benefits of having a mammogram with their doctor and decide what to do on an individual basis.
"But our data show that women who undergo regular mammography screening present at earlier stages and often require less aggressive treatment than those who do not,” says Jamie Caughran, MD, medical director of the Comprehensive Breast Center at the Lacks Cancer Center in Grand Rapids, Mich.
"This is true for women older than 50 years, as well as women aged 40 to 49 years for whom routine mammography is questioned by the USPSTF.”
The American Cancer Society and the American College of Radiology continue to advise women to begin routine screening annually at age 40.
In 2011, more than 290,000 cases of breast cancer are expected to occur in the U.S. Women under 50 account for at least one-fourth of breast cancer diagnoses.
Caughran presented the findings at a news briefing held in advance of the Breast Cancer Symposium in San Francisco.
Using a statewide breast cancer registry, the researchers examined data on 5,903 women diagnosed and treated for breast cancer between 2006 and 2009.
Among the findings:
Caughran says that although the cost of a mammogram is obviously more than that of self-exam, that needs to be weighed against that fact that finding by touch is associated with more aggressive treatment.
Daniel B. Kopans, MD, professor of radiology at Harvard Medical School, says, "This paper reinforces what many of us have been saying ever since the USPSTF guidelines were issued. Mammography screening saves lives and women should be encouraged to participate from age 40."
A study that used computer models showed that as many as 100,000 lives would be lost unnecessarily among women who are now in their 30s if the USPSTF, rather than the American Cancer Society, guidelines were followed, he tells WebMD.
But George F. Sawaya, MD, says that the researchers fail to mention potential harms -- including anxiety, unnecessary biopsies, and unnecessary treatment of cancers that would never become life threatening -- against which one might weigh benefits. Sawaya was a member of the Task Force but stresses that he is not speaking on its behalf.
"Women aged 40 to 49 years are not omitted from the USPSTF guidelines. The recommendation for women under 50 years is to make individualized decisions based on benefits and harms," says Sawaya, professor of obstetrics, gynecology and reproductive sciences and epidemiology and biostatistics at the University of California, San Francisco.
Caughran counters, "Ask a woman if she'd rather go through the anxiety of an unnecessary biopsy or miss a cancer, and I think she'd pick the former."
These findings were presented at a medical conference. They should be considered preliminary as they have not yet undergone the "peer review" process, in which outside experts scrutinize the data prior to publication in a medical journal.
SOURCESBreast Cancer Symposium 2011, San Francisco, Sept. 6, 2011.Jamie Caughran, MD, medical director, Comprehensive Breast Center, Lacks Cancer Center, Grand Rapids, Mich.Daniel B. Kopans, MD, professor of radiology, Harvard Medical School, Boston.George F. Sawaya, MD, former member, U.S. Preventive Services Task Force; professor, obstetrics, gynecology and reproductive sciences and epidemiology and biostatistics, University of California, San Francisco.
Here are the most recent story comments.View All
The views expressed here do not necessarily represent those of CW Arkansas
The Health News section does not provide medical advice, diagnosis or treatment. See additional information.